CARISOPRODOL vs CASPOFUNGIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARISOPRODOL vs CASPOFUNGIN: Safety Overview
| Metric | CARISOPRODOL | CASPOFUNGIN |
|---|---|---|
| Total FAERS Reports | 2,660 | 3,814 |
| Deaths Reported | 1,332 | 1,419 |
| Death Rate | 50.1% | 37.2% |
| Hospitalizations | 432 | 1,638 |
| Average Patient Age | 48.1 yrs | 47.5 yrs |
| % Female Patients | 63.6% | 42.8% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Dec 30, 2016 |
| Manufacturer | ScieGen Pharmaceuticals, Inc. | Sandoz Inc |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |